MicroRNAs in myeloid malignancies

British Journal of Haematology

Volumn 162, Issue 2, 2013, Pages 162-176

  Gordon, Jane E A ^a   Wong, Justin J L ^a   Rasko, John E J ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acute myeloid leukaemia; Chronic myeloid leukaemia; Leukaemia; MicroRNAs; Myeloid

Indexed keywords

BCR ABL PROTEIN; BCR ABL1 PROTEIN; CORE BINDING FACTOR; MESSENGER RNA; MICRORNA; MICRORNA 125B; MICRORNA 125B2; MICRORNA 126; MICRORNA 142 3P; MICRORNA 150; MICRORNA 17HG; MICRORNA 181A; MICRORNA 181B; MICRORNA 196B; MICRORNA 223; MICRORNA 29; MICRORNA 29A; MICRORNA 328; MICRORNA 495; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR RUNX1; TUMOR MARKER; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; BAALC GENE; CEBPA GENE; CHROMOSOME 11Q; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CREBBP GENE; DISEASE MARKER; DOWN REGULATION; ERG GENE; ERYTHROLEUKEMIA; FLT3 ITD GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TRANSLOCATION; HUMAN; KIT GENE; MUTATIONAL ANALYSIS; MYELOID LEUKEMIA; NONHUMAN; NPM1 GENE; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW; TUMOR GENE; UPREGULATION;

ACUTE MYELOID LEUKAEMIA; CHRONIC MYELOID LEUKAEMIA; LEUKAEMIA; MICRORNAS; MYELOID;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MICRORNAS; MYELOPROLIFERATIVE DISORDERS;

EID: 84879839817     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12364     Document Type: Review

References (151)

1. Agirre, X., Jiménez-Velasco, A., San José-Enériz, E., Garate, L., Bandres, E., Cordeu, L., Aparicio, O., Saez, B., Navarro, G., Vilas-Zornoza, A., Pérez-Roger, I., Garcia-Foncillas, J., Torres, A., Heiniger, A., Calasanz, M.J., Fortes, P., Román-Gómez, J. & Prósper, F. (2008) Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34 + cells increases USF2-mediated cell growth. Molecular Cancer Research, 6, 1830-1840.
2. Ambros, V. & Horvitz, H.R. (1984) Heterochronic mutants of the nematode Caenorhabditis elegans. Science, 226, 409-416.
3. Bagga, S., Bracht, J., Hunter, S., Massirer, K., Holtz, J., Eachus, R. & Pasquinelli, A.E. (2005) Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell, 122, 553-563.
4. Baldus, C.D., Tanner, S.M., Ruppert, A.S., Whitman, S.P., Archer, K.J., Marcucci, G., Caligiuri, M.A., Carroll, A.J., Vardiman, J.W., Powell, B.L., Allen, S.L., Moore, J.O., Larson, R.A., Kolitz, J.E., de la Chapelle, A. & Bloomfield, C.D. (2003) BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. Blood, 102, 1613-1618.
5. Becker, H., Marcucci, G., Maharry, K., Radmacher, M.D., Mrozek, K., Margeson, D., Whitman, S.P., Wu, Y.Z., Schwind, S., Paschka, P., Powell, B.L., Carter, T.H., Kolitz, J.E., Wetzler, M., Carroll, A.J., Baer, M.R., Caligiuri, M.A., Larson, R.A. & Bloomfield, C.D. (2010) Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. Journal of Clinical Oncology, 28, 596-604.
6. Beghini, A., Ripamonti, C.B., Cairoli, R., Cazzaniga, G., Colapietro, P., Elice, F., Nadali, G., Grillo, G., Haas, O.A., Biondi, A., Morra, E. & Larizza, L. (2004) KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication. Haematologica, 89, 920-925.
7. Berezikov, E. (2011) Evolution of microRNA diversity and regulation in animals. Nature Reviews Genetics, 12, 846-860.
8. Blum, W., Garzon, R., Klisovic, R.B., Schwind, S., Walker, A., Geyer, S., Liu, S., Havelange, V., Becker, H., Schaaf, L., Mickle, J., Devine, H., Kefauver, C., Devine, S.M., Chan, K.K., Heerema, N.A., Bloomfield, C.D., Grever, M.R., Byrd, J.C., Villalona-Calero, M., Croce, C.M. & Marcucci, G. (2010) Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine. Proceedings of the National Academy of Sciences of the United States of America, 107, 7473-7478.
9. Borchert, G.M., Lanier, W. & Davidson, B.L. (2006) RNA polymerase III transcribes human microRNAs. Nature Structural and Molecular Biology, 13, 1097-1101.
10. Borze, I., Guled, M., Musse, S., Raunio, A., Elonen, E., Saarinen-Pihkala, U., Karjalainen-Lindsberg, M.L., Lahti, L. & Knuutila, S. (2011) MicroRNA microarrays on archive bone marrow core biopsies of leukemias - method validation. Leukemia Research, 35, 188-195.
11. Bousquet, M., Quelen, C., Rosati, R., Mansat-De Mas, V., La Starza, R., Bastard, C., Lippert, E., Talmant, P., Lafage-Pochitaloff, M., Leroux, D., Gervais, C., Viguie, F., Lai, J.L., Terre, C., Beverlo, B., Sambani, C., Hagemeijer, A., Marynen, P., Delsol, G., Dastugue, N., Mecucci, C. & Brousset, P. (2008) Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. Journal of Experimental Medicine, 205, 2499-2506.
12. Brameier, M., Herwig, A., Reinhardt, R., Walter, L. & Gruber, J. (2011) Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Research, 39, 675-686.
13. Brennecke, J., Hipfner, D.R., Stark, A., Russell, R.B. & Cohen, S.M. (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell, 113, 25-36.
14. Brioschi, M., Fischer, J., Cairoli, R., Rossetti, S., Pezzetti, L., Nichelatti, M., Turrini, M., Corlazzoli, F., Scarpati, B., Morra, E., Sacchi, N. & Beghini, A. (2010) Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits. Neoplasia, 12, 866-876.
15. Broderick, J.A. & Zamore, P.D. (2011) MicroRNA therapeutics. Gene Therapy, 18, 1104-1110.
16. Bryant, A., Palma, C.A., Jayaswal, V., Yang, Y.W., Lutherborrow, M. & Ma, D.D. (2012) miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death. Molecular Cancer, 11, 8.
17. Bueno, M.J., Peréz de Castro, I., Gómez de Cedrón, M., Santos, J., Calin, G.A., Cigudosa, J.C., Croce, C.M., Fernández-Piqueras, J. & Malumbres, M. (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell, 13, 496-506.
18. Cairoli, R., Beghini, A., Grillo, G., Nadali, G., Elice, F., Ripamonti, C.B., Colapietro, P., Nichelatti, M., Pezzetti, L., Lunghi, M., Cuneo, A., Viola, A., Ferrara, F., Lazzarino, M., Rodeghiero, F., Pizzolo, G., Larizza, L. & Morra, E. (2006) Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood, 107, 3463-3468.
19. Calin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., Rassenti, L., Kipps, T., Negrini, M., Bullrich, F. & Croce, C.M. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 99, 15524-15529.
20. Calin, G.A., Liu, C.-G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C.D., Shimizu, M., Cimmino, A., Zupo, S., Dono, M., Dell'Aquila, M.L., Alder, H., Rassenti, L., Kipps, T.J., Bullrich, F., Negrini, M. & Croce, C.M. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proceedings of the National Academy of Sciences of the United States of America, 101, 11755-11760.
21. Cammarata, G., Augugliaro, L., Salemi, D., Agueli, C., La Rosa, M., Dagnino, L., Civiletto, G., Messana, F., Marfia, A., Bica, M.G., Cascio, L., Floridia, P.M., Mineo, A.M., Russo, M., Fabbiano, F. & Santoro, A. (2010) Differential expression of specific microRNA and their targets in acute myeloid leukemia. American Journal of Hematology, 85, 331-339.
22. Care, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M.L., Segnalini, P., Gu, Y., Dalton, N.D., Elia, L., Latronico, M.V., Hoydal, M., Autore, C., Russo, M.A., Dorn, G.W. 2nd, Ellingsen, O., Ruiz-Lozano, P., Peterson, K.L., Croce, C.M., Peschle, C. & Condorelli, G. (2007) MicroRNA-133 controls cardiac hypertrophy. Nature Medicine, 13, 613-618.
23. Chan, J.A., Krichevsky, A.M. & Kosik, K.S. (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Research, 65, 6029-6033.
24. Chang, J.S., Santhanam, R., Trotta, R., Neviani, P., Eiring, A.M., Briercheck, E., Ronchetti, M., Roy, D.C., Calabretta, B., Caligiuri, M.A. & Perrotti, D. (2007) High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. Blood, 110, 994-1003.
25. Cheloufi, S., Dos Santos, C.O., Chong, M.M.W. & Hannon, G.J. (2010) A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature, 465, 584-589.
26. Chen, C., Ridzon, D.A., Broomer, A.J., Zhou, Z., Lee, D.H., Nguyen, J.T., Barbisin, M., Xu, N.L., Mahuvakar, V.R., Andersen, M.R., Lao, K.Q., Livak, K.J. & Guegler, K.J. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research, 33, e179.
27. Chen, J., Odenike, O. & Rowley, J.D. (2010) Leukaemogenesis: more than mutant genes. Nature Reviews Cancer, 10, 23-36.
28. Cheng, C.K., Kwan, T.K., Cheung, C.Y., Ng, K., Liang, P., Cheng, S.H., Chan, N.P., Ip, R.K., Wong, R.S., Lee, V., Li, C.K., Yip, S.F. & Ng, M.H. (2012) A polymorphism in the 3′-untranslated region of the NPM1 gene causes illegitimate regulation by microRNA-337-5p and correlates with adverse outcome in acute myeloid leukemia. Haematologica, doi: 10.3324/haematol.2012.073015.
29. Cifuentes, D., Xue, H., Taylor, D.W., Patnode, H., Mishima, Y., Cheloufi, S., Ma, E., Mane, S., Hannon, G.J., Lawson, N.D., Wolfe, S.A. & Giraldez, A.J. (2010) A novel miRNA processing pathway independent of dicer requires argonaute2 catalytic activity. Science, 328, 1694-1698.
30. Corbin, A.S., Agarwal, A., Loriaux, M., Cortes, J., Deininger, M.W. & Druker, B.J. (2011) Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. The Journal of Clinical Investigation, 121, 396-409.
31. Coskun, E., von der Heide, E.K., Schlee, C., Kühnl, A., Gokbuget, N., Hoelzer, D., Hofmann, W.K., Thiel, E. & Baldus, C.D. (2011) The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia. Leukemia Research, 35, 208-213.
32. Daley, G.Q., Van Etten, R.A. & Baltimore, D. (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science, 247, 824-830.
33. Danen-van Oorschot, A.A., Kuipers, J.E., Arentsen-Peters, S., Schotte, D., de Haas, V., Trka, J., Baruchel, A., Reinhardt, D., Pieters, R., Zwaan, C.M. & van den Heuvel-Eibrink, M.M. (2012) Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Pediatric Blood and Cancer, 58, 715-721.
34. Davis, S., Propp, S., Freier, S.M., Jones, L.E., Serra, M.J., Kinberger, G., Bhat, B., Swayze, E.E., Bennett, C.F. & Esau, C. (2009) Potent inhibition of microRNA in vivo without degradation. Nucleic Acids Research, 37, 70-77.
35. De Weer, A., Van der Meulen, J., Rondou, P., Taghon, T., Konrad, T.A., De Preter, K., Mestdagh, P., Van Maerken, T., Van Roy, N., Jeison, M., Yaniv, I., Cauwelier, B., Noens, L., Poirel, H.A., Vandenberghe, P., Lambert, F., De Paepe, A., Sánchez, M.G., Odero, M., Verhasselt, B., Philippé, J., Vandesompele, J., Wieser, R., Dastugue, N., Van Vlierberghe, P., Poppe, B. & Speleman, F. (2011) EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells. British Journal of Haematology, 154, 337-348.
36. Denli, A.M., Tops, B.B.J., Plasterk, R.H.A., Ketting, R.F. & Hannon, G.J. (2004) Processing of primary microRNAs by the Microprocessor complex. Nature, 432, 231-235.
37. Díaz-Beyá, M., Navarro, A., Ferrer, G., Diaz, T., Gel, B., Camós, M., Pratcorona, M., Torrebadell, M., Rozman, M., Colomer, D., Monzo, M. & Esteve, J. (2013) Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. Leukemia, 27, 595-603.
38. Dixon-McIver, A., East, P., Mein, C.A., Cazier, J.B., Molloy, G., Chaplin, T., Andrew Lister, T., Young, B.D. & Debernardi, S. (2008) Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One, 3, e2141.
39. Djuranovic, S., Nahvi, A. & Green, R. (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science, 336, 237-240.
40. Ebert, M.S. & Sharp, P.A. (2010) MicroRNA sponges: progress and possibilities. RNA, 16, 2043-2050.
41. Ebert, M.S., Neilson, J.R. & Sharp, P.A. (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nature Methods, 4, 721-726.
42. Eiring, A.M., Harb, J.G., Neviani, P., Garton, C., Oaks, J.J., Spizzo, R., Liu, S., Schwind, S., Santhanam, R., Hickey, C.J., Becker, H., Chandler, J.C., Andino, R., Cortes, J., Hokland, P., Huettner, C.S., Bhatia, R., Roy, D.C., Liebhaber, S.A., Caligiuri, M.A., Marcucci, G., Garzon, R., Croce, C.M., Calin, G.A. & Perrotti, D. (2010) miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell, 140, 652-665.
43. Eisfeld, A.K., Marcucci, G., Maharry, K., Schwind, S., Radmacher, M.D., Nicolet, D., Becker, H., Mrózek, K., Whitman, S.P., Metzeler, K.H., Mendler, J.H., Wu, Y.Z., Liyanarachchi, S., Patel, R., Baer, M.R., Powell, B.L., Carter, T.H., Moore, J.O., Kolitz, J.E., Wetzler, M., Caligiuri, M.A., Larson, R.A., Tanner, S.M., de la Chapelle, A. & Bloomfield, C.D. (2012) miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia. Blood, 120, 249-258.
44. Ender, C., Krek, A., Friedländer, M.R., Beitzinger, M., Weinmann, L., Chen, W., Pfeffer, S., Rajewsky, N. & Meister, G. (2008) A human snoRNA with microRNA-like functions. Molecular Cell, 32, 519-528.
45. Eyholzer, M., Schmid, S., Wilkens, L., Mueller, B.U. & Pabst, T. (2010) The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. British Journal of Cancer, 103, 275-284.
46. Fabbri, M. & Croce, C.M. (2011) Role of microRNAs in lymphoid biology and disease. Current opinion in hematology, 18, 266-272.
47. Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M.L., Nervi, C. & Bozzoni, I. (2005) A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell, 123, 819-831.
48. Fazi, F., Racanicchi, S., Zardo, G., Starnes, L.M., Mancini, M., Travaglini, L., Diverio, D., Ammatuna, E., Cimino, G., Lo-Coco, F., Grignani, F. & Nervi, C. (2007) Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell, 12, 457-466.
49. Fei, J., Li, Y., Zhu, X. & Luo, X. (2012) miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). PLoS One, 7, e32834.
50. Felli, N., Fontana, L., Pelosi, E., Botta, R., Bonci, D., Facchiano, F., Liuzzi, F., Lulli, V., Morsilli, O., Santoro, S., Valtieri, M., Calin, G.A., Liu, C.G., Sorrentino, A., Croce, C.M. & Peschle, C. (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proceedings of the National Academy of Sciences of the United States of America, 102, 18081-18086.
51. Flamant, S., Ritchie, W., Guilhot, J., Holst, J., Bonnet, M.L., Chomel, J.C., Guilhot, F., Turhan, A.G. & Rasko, J.E. (2010) Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica, 95, 1325-1333.
52. Franco-Zorrilla, J.M., Valli, A., Todesco, M., Mateos, I., Puga, M.I., Rubio-Somoza, I., Leyva, A., Weigel, D., Garcia, J.A. & Paz-Ares, J. (2007) Target mimicry provides a new mechanism for regulation of microRNA activity. Nature Genetics, 39, 1033-1037.
53. Gao, X.N., Lin, J., Li, Y.H., Gao, L., Wang, X.R., Wang, W., Kang, H.Y., Yan, G.T., Wang, L.L. & Yu, L. (2011a) MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Oncogene, 30, 3416-3428.
54. Gao, X.N., Lin, J., Gao, L., Li, Y.H., Wang, L.L. & Yu, L. (2011b) MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia. Leukemia Research, 35, 1226-1232.
55. Garofalo, M. & Croce, C.M. (2011) microRNAs: Master regulators as potential therapeutics in cancer. Annual Review of Pharmacology and Toxicology, 51, 25-43.
56. Garzon, R., Volinia, S., Liu, C.G., Fernandez-Cymering, C., Palumbo, T., Pichiorri, F., Fabbri, M., Coombes, K., Alder, H., Nakamura, T., Flomenberg, N., Marcucci, G., Calin, G.A., Kornblau, S.M., Kantarjian, H., Bloomfield, C.D., Andreeff, M. & Croce, C.M. (2008a) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood, 111, 3183-3189.
57. Garzon, R., Garofalo, M., Martelli, M.P., Briesewitz, R., Wang, L., Fernandez-Cymering, C., Volinia, S., Liu, C.G., Schnittger, S., Haferlach, T., Liso, A., Diverio, D., Mancini, M., Meloni, G., Foa, R., Martelli, M.F., Mecucci, C., Croce, C.M. & Falini, B. (2008b) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proceedings of the National Academy of Sciences of the United States of America, 105, 3945-3950.
58. Garzon, R., Liu, S., Fabbri, M., Liu, Z., Heaphy, C.E.A., Callegari, E., Schwind, S., Pang, J., Yu, J., Muthusamy, N., Havelange, V., Volinia, S., Blum, W., Rush, L.J., Perrotti, D., Andreeff, M., Bloomfield, C.D., Byrd, J.C., Chan, K., Wu, L.-C., Croce, C.M. & Marcucci, G. (2009a) MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood, 113, 6411-6418.
59. Garzon, R., Heaphy, C.E., Havelange, V., Fabbri, M., Volinia, S., Tsao, T., Zanesi, N., Kornblau, S.M., Marcucci, G., Calin, G.A., Andreeff, M. & Croce, C.M. (2009b) MicroRNA 29b functions in acute myeloid leukemia. Blood, 114, 5331-5341.
60. Garzon, R., Marcucci, G. & Croce, C.M. (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nature Reviews Drug Discovery, 9, 775-789.
61. Gilliland, D.G. & Griffin, J.D. (2002) The roles of FLT3 in hematopoiesis and leukemia. Blood, 100, 1532-1542.
62. Grimson, A., Farh, K.K.-H., Johnston, W.K., Garrett-Engele, P., Lim, L.P. & Bartel, D.P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Molecular Cell, 27, 91-105.
63. Hammond, S.M., Bernstein, E., Beach, D. & Hannon, G.J. (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature, 404, 293-296.
64. Han, Y.C., Park, C.Y., Bhagat, G., Zhang, J., Wang, Y., Fan, J.B., Liu, M., Zou, Y., Weissman, I.L. & Gu, H. (2010) microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. Journal of Experimental Medicine, 207, 475-489.
65. Havelange, V. & Garzon, R. (2010) MicroRNAs: emerging key regulators of hematopoiesis. American Journal of Hematology, 85, 935-942.
66. Hershkovitz Rokah, O., Granot, G., Ovcharenko, A., Modai, S., Pasmanik-Chor, M., Toren, A., Shomron, N. & Shpilberg, O. (2012) Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells. PLoS One, 7, e35501.
67. Heuser, M., Beutel, G., Krauter, J., Döhner, K., von Neuhoff, N., Schlegelberger, B. & Ganser, A. (2006) High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood, 108, 3898-3905.
68. Hutvägner, G., McLachlan, J., Pasquinelli, A.E., Bálint, É., Tuschl, T. & Zamore, P.D. (2001) A cellular function for the RNA-interference enzyme dicer in the maturation of the let-7 small temporal RNA. Science, 293, 834-838.
69. Jiang, X., Huang, H., Li, Z., He, C., Li, Y., Chen, P., Gurbuxani, S., Arnovitz, S., Hong, G.M., Price, C., Ren, H., Kunjamma, R.B., Neilly, M.B., Salat, J., Wunderlich, M., Slany, R.K., Zhang, Y., Larson, R.A., Le Beau, M.M., Mulloy, J.C., Rowley, J.D. & Chen, J. (2012) miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proceedings of the National Academy of Sciences of the United States of America, 109, 19397-19402.
70. Johnnidis, J.B., Harris, M.H., Wheeler, R.T., Stehling-Sun, S., Lam, M.H., Kirak, O., Brummelkamp, T.R., Fleming, M.D. & Camargo, F.D. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature, 451, 1125-1129.
71. Jongen-Lavrencic, M., Sun, S.M., Dijkstra, M.K., Valk, P.J. & Löwenberg, B. (2008) MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood, 111, 5078-5085.
72. Kayali, S., Giraud, G., Morlé, F. & Guyot, B. (2012) Spi-1, Fli-1 and Fli-3 (miR-17-92) oncogenes contribute to a single oncogenic network controlling cell proliferation in Friend Erythroleukemia. PLoS One, 7, e46799.
73. Kim, K.T., Carroll, A.P., Mashkani, B., Cairns, M.J., Small, D. & Scott, R.J. (2012) MicroRNA-16 is down-regulated in mutated FLT3 expressing murine myeloid FDC-P1 cells and interacts with Pim-1. PLoS One, 7, e44546.
74. Kindler, T., Breitenbuecher, F., Marx, A., Beck, J., Hess, G., Weinkauf, B., Duyster, J., Peschel, C., Kirkpatrick, C.J., Theobald, M., Gschaidmeier, H., Huber, C. & Fischer, T. (2004) Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia. Blood, 103, 3644-3654.
75. Kluiver, J., Slezak-Prochazka, I., Smigielska-Czepiel, K., Halsema, N., Kroesen, B.J. & van den Berg, A. (2012) Generation of miRNA sponge constructs. Methods, 58, 113-117.
76. Klusmann, J.H., Li, Z., Bohmer, K., Maroz, A., Koch, M.L., Emmrich, S., Godinho, F.J., Orkin, S.H. & Reinhardt, D. (2010) miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes and Development, 24, 478-490.
77. Kooijmans, S.A., Vader, P., van Dommelen, S.M., van Solinge, W.W. & Schiffelers, R.M. (2012) Exosome mimetics: a novel class of drug delivery systems. International Journal of Nanomedicine, 7, 1525-1541.
78. Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K.G., Tuschl, T., Manoharan, M. & Stoffel, M. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature, 438, 685-689.
79. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. (2001) Identification of novel genes coding for small expressed RNAs. Science, 294, 853-858.
80. Landthaler, M., Yalcin, A. & Tuschl, T. (2004) The human DiGeorge Syndrome Critical Region Gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Current Biology, 14, 2162-2167.
81. Langer, C., Marcucci, G., Holland, K.B., Radmacher, M.D., Maharry, K., Paschka, P., Whitman, S.P., Mrozek, K., Baldus, C.D., Vij, R., Powell, B.L., Carroll, A.J., Kolitz, J.E., Caligiuri, M.A., Larson, R.A. & Bloomfield, C.D. (2009) Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. Journal of Clinical Oncology, 27, 3198-3204.
82. Lau, N.C., Lim, L.P., Weinstein, E.G. & Bartel, D.P. (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science, 294, 858-862.
83. Lechman, E., Gentner, B., Hiramatsu, H., Hope, K., Takenaka, K., Eppert, K., Minden, M., Naldini, L. & Dick, J. (2010) Enriched microRNA-126 bioactivity marks the primitive compartment in AML and regulates LSC numbers. Blood (ASH Annual Meeting Abstracts), 116, 94.
84. Lee, R.C., Feinbaum, R.L. & Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-854.
85. Lee, T.Y., Ezelle, H.J., Venkataraman, T., Lapidus, R.G., Scheibner, K.A. & Hassel, B.A. (2013) Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia. Journal of Interferon and Cytokine Research, 33, 34-42.
86. Lennox, K.A. & Behlke, M.A. (2011) Chemical modification and design of anti-miRNA oligonucleotides. Gene Therapy, 18, 1111-1120.
87. Lewis, B.P., Burge, C.B. & Bartel, D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
88. Li, Z., Lu, J., Sun, M., Mi, S., Zhang, H., Luo, R.T., Chen, P., Wang, Y., Yan, M., Qian, Z., Neilly, M.B., Jin, J., Zhang, Y., Bohlander, S.K., Zhang, D.E., Larson, R.A., Le Beau, M.M., Thirman, M.J., Golub, T.R., Rowley, J.D. & Chen, J. (2008) Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proceedings of the National Academy of Sciences of the United States of America, 105, 15535-15540.
89. Li, Z., Huang, H., Li, Y., Jiang, X., Chen, P., Arnovitz, S., Radmacher, M.D., Maharry, K., Elkahloun, A., Yang, X., He, C., He, M., Zhang, Z., Dohner, K., Neilly, M.B., Price, C., Lussier, Y.A., Zhang, Y., Larson, R.A., Le Beau, M.M., Caligiuri, M.A., Bullinger, L., Valk, P.J., Delwel, R., Lowenberg, B., Liu, P.P., Marcucci, G., Bloomfield, C.D., Rowley, J.D. & Chen, J. (2012a) Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood, 119, 2314-2324.
90. Li, Y., Vecchiarelli-Federico, L.M., Li, Y.J., Egan, S.E., Spaner, D., Hough, M.R. & Ben-David, Y. (2012b) The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice. Blood, 119, 4486-4498.
91. Lidonnici, M.R., Corradini, F., Waldron, T., Bender, T.P. & Calabretta, B. (2008) Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis. Blood, 111, 4771-4779.
92. Liu, J., Valencia-Sanchez, M.A., Hannon, G.J. & Parker, R. (2005) MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nature Cell Biology, 7, 719-723.
93. Liu, A., Tetzlaff, M.T., Vanbelle, P., Elder, D., Feldman, M., Tobias, J.W., Sepulveda, A.R. & Xu, X. (2009) MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues. International Journal of Clinical and Experimental Pathology, 2, 519-527.
94. Liu, S., Wu, L.C., Pang, J., Santhanam, R., Schwind, S., Wu, Y.Z., Hickey, C.J., Yu, J., Becker, H., Maharry, K., Radmacher, M.D., Li, C., Whitman, S.P., Mishra, A., Stauffer, N., Eiring, A.M., Briesewitz, R., Baiocchi, R.A., Chan, K.K., Paschka, P., Caligiuri, M.A., Byrd, J.C., Croce, C.M., Bloomfield, C.D., Perrotti, D., Garzon, R. & Marcucci, G. (2010) Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell, 17, 333-347.
95. Lu, D.P., Read, R.L., Humphreys, D.T., Battah, F.M., Martin, D.I. & Rasko, J.E. (2005) PCR-based expression analysis and identification of microRNAs. Journal of RNAi and Gene Silencing, 1, 44-49.
96. Lugo, T.G., Pendergast, A.M., Muller, A.J. & Witte, O.N. (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science, 247, 1079-1082.
97. Machová Poláková, K., Lopotová, T., Klamová, H., Burda, P., Trněný, M., Stopka, T. & Moravcová, J. (2011) Expression patterns of microRNAs associated with CML phases and their disease related targets. Molecular Cancer, 10, 41.
98. Marcucci, G., Maharry, K., Whitman, S.P., Vukosavljevic, T., Paschka, P., Langer, C., Mrózek, K., Baldus, C.D., Carroll, A.J., Powell, B.L., Kolitz, J.E., Larson, R.A. & Bloomfield, C.D. (2007) High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. Journal of Clinical Oncology, 25, 3337-3343.
99. Marcucci, G., Radmacher, M.D., Maharry, K., Mrózek, K., Ruppert, A.S., Paschka, P., Vukosavljevic, T., Whitman, S.P., Baldus, C.D., Langer, C., Liu, C.-G., Carroll, A.J., Powell, B.L., Garzon, R., Croce, C.M., Kolitz, J.E., Caligiuri, M.A., Larson, R.A. & Bloomfield, C.D. (2008a) MicroRNA expression in cytogenetically normal acute myeloid leukemia. New England Journal of Medicine, 358, 1919-1928.
100. Marcucci, G., Maharry, K., Radmacher, M.D., Mrozek, K., Vukosavljevic, T., Paschka, P., Whitman, S.P., Langer, C., Baldus, C.D., Liu, C.G., Ruppert, A.S., Powell, B.L., Carroll, A.J., Caligiuri, M.A., Kolitz, J.E., Larson, R.A. & Bloomfield, C.D. (2008b) Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. Journal of Clinical Oncology, 26, 5078-5087.
101. Marcucci, G., Haferlach, T. & Döhner, H. (2011a) Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. Journal of Clinical Oncology, 29, 475-486.
102. Marcucci, G., Mrózek, K., Radmacher, M.D., Garzon, R. & Bloomfield, C.D. (2011b) The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood, 117, 1121-1129.
103. McLaughlin, J., Chianese, E. & Witte, O.N. (1987) In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proceedings of the National Academy of Sciences of the United States of America, 84, 6558-6562.
104. McLaughlin, J., Cheng, D., Singer, O., Lukacs, R.U., Radu, C.G., Verma, I.M. & Witte, O.N. (2007) Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics. Proceedings of the National Academy of Sciences of the United States of America, 104, 20501-20506.
105. Mi, S., Lu, J., Sun, M., Li, Z., Zhang, H., Neilly, M.B., Wang, Y., Qian, Z., Jin, J., Zhang, Y., Bohlander, S.K., Le Beau, M.M., Larson, R.A., Golub, T.R., Rowley, J.D. & Chen, J. (2007) MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America, 104, 19971-19976.
106. Mi, S., Li, Z., Chen, P., He, C., Cao, D., Elkahloun, A., Lu, J., Pelloso, L.A., Wunderlich, M., Huang, H., Luo, R.T., Sun, M., He, M., Neilly, M.B., Zeleznik-Le, N.J., Thirman, M.J., Mulloy, J.C., Liu, P.P., Rowley, J.D. & Chen, J. (2010) Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proceedings of the National Academy of Sciences of the United States of America, 107, 3710-3715.
107. Mrózek, K., Prior, T.W., Edwards, C., Marcucci, G., Carroll, A.J., Snyder, P.J., Koduru, P.R., Theil, K.S., Pettenati, M.J., Archer, K.J., Caligiuri, M.A., Vardiman, J.W., Kolitz, J.E., Larson, R.A. & Bloomfield, C.D. (2001) Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. Journal of Clinical Oncology, 19, 2482-2492.
108. Nowell, P.C. & Hungerford, D.A. (1960) Chromosome studies on normal and leukemic human leukocytes. Journal of the National Cancer Institute, 25, 85-109.
109. Nucifora, G., Begy, C.R., Kobayashi, H., Roulston, D., Claxton, D., Pedersen-Bjergaard, J., Parganas, E., Ihle, J.N. & Rowley, J.D. (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proceedings of the National Academy of Sciences of the United States of America, 91, 4004-4008.
110. Ovcharenko, D., Stölzel, F., Poitz, D., Fierro, F., Schaich, M., Neubauer, A., Kelnar, K., Davison, T., Müller-Tidow, C., Thiede, C., Bornhäuser, M., Ehninger, G., Brown, D. & Illmer, T. (2011) miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia. Experimental Hematology, 39, 1030-1042.e1037.
111. Pasquinelli, A.E., Reinhart, B.J., Slack, F., Martindale, M.Q., Kuroda, M.I., Maller, B., Hayward, D.C., Ball, E.E., Degnan, B., Müller, P., Spring, J., Srinivasan, A., Fishman, M., Finnerty, J., Corbo, J., Levine, M., Leahy, P., Davidson, E. & Ruvkun, G. (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 408, 86-89.
112. Pigazzi, M., Manara, E., Bresolin, S., Tregnago, C., Beghin, A., Baron, E., Giarin, E., Cho, E.C., Masetti, R., Rao, D.S., Sakamoto, K.M. & Basso, G. (2013) MiR-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation. Haematologica, 98, 602-610.
113. Pillai, R.S., Bhattacharyya, S.N., Artus, C.G., Zoller, T., Cougot, N., Basyuk, E., Bertrand, E. & Filipowicz, W. (2005) Inhibition of translational initiation by Let-7 microRNA in human cells. Science, 309, 1573-1576.
114. Popovic, R., Riesbeck, L.E., Velu, C.S., Chaubey, A., Zhang, J., Achille, N.J., Erfurth, F.E., Eaton, K., Lu, J., Grimes, H.L., Chen, J., Rowley, J.D. & Zeleznik-Le, N.J. (2009) Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood, 113, 3314-3322.
115. Pritchard, C.C., Cheng, H.H. & Tewari, M. (2012) MicroRNA profiling: approaches and considerations. Nature Reviews Genetics, 13, 358-369.
116. Pulikkan, J.A., Dengler, V., Peramangalam, P.S., Peer Zada, A.A., Müller-Tidow, C., Bohlander, S.K., Tenen, D.G. & Behre, G. (2010a) Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood, 115, 1768-1778.
117. Pulikkan, J.A., Peramangalam, P.S., Dengler, V., Ho, P.A., Preudhomme, C., Meshinchi, S., Christopeit, M., Nibourel, O., Müller-Tidow, C., Bohlander, S.K., Tenen, D.G. & Behre, G. (2010b) C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood, 116, 5638-5649.
118. Ramsingh, G., Koboldt, D.C., Trissal, M., Chiappinelli, K.B., Wylie, T., Koul, S., Chang, L.W., Nagarajan, R., Fehniger, T.A., Goodfellow, P., Magrini, V., Wilson, R.K., Ding, L., Ley, T.J., Mardis, E.R. & Link, D.C. (2010) Complete characterization of the microRNAome in a patient with acute myeloid leukemia. Blood, 116, 5316-5326.
119. Ross, D.M., Branford, S., Seymour, J.F., Schwarer, A.P., Arthur, C., Bartley, P.A., Slader, C., Field, C., Dang, P., Filshie, R.J., Mills, A.K., Grigg, A.P., Melo, J.V. & Hughes, T.P. (2010) Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR. Leukemia, 24, 1719-1724.
120. Ruby, J.G., Jan, C.H. & Bartel, D.P. (2007) Intronic microRNA precursors that bypass Drosha processing. Nature, 448, 83-86.
121. Russ, A.C., Sander, S., Lück, S.C., Lang, K.M., Bauer, M., Rucker, F.G., Kestler, H.A., Schlenk, R.F., Döhner, H., Holzmann, K., Döhner, K. & Bullinger, L. (2011) Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia. Haematologica, 96, 1783-1791.
122. San José-Enériz, E., Román-Gómez, J., Jiménez-Velasco, A., Garate, L., Martin, V., Cordeu, L., Vilas-Zornoza, A., Rodríguez-Otero, P., Calasanz, M.J., Prósper, F. & Agirre, X. (2009) MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations. Molecular Cancer, 8, 69.
123. Saumet, A., Vetter, G., Bouttier, M., Portales-Casamar, E., Wasserman, W.W., Maurin, T., Mari, B., Barbry, P., Vallar, L., Friederich, E., Arar, K., Cassinat, B., Chomienne, C. & Lecellier, C.H. (2009) Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia. Blood, 113, 412-421.
124. Sayed, D., Rane, S., Lypowy, J., He, M., Chen, I.Y., Vashistha, H., Yan, L., Malhotra, A., Vatner, D. & Abdellatif, M. (2008) MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Molecular Biology of the Cell, 19, 3272-3282.
125. Shankar, D.B., Cheng, J.C., Kinjo, K., Federman, N., Moore, T.B., Gill, A., Rao, N.P., Landaw, E.M. & Sakamoto, K.M. (2005) The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell, 7, 351-362.
126. Sokal, J.E., Cox, E.B., Baccarani, M., Tura, S., Gomez, G.A., Robertson, J.E., Tso, C.Y., Braun, T.J., Clarkson, B.D., Cervantes, F. & Rozman, C.; The Italian Cooperative CML Study Group. (1984) Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood, 63, 789-799.
127. Sokol, L., Caceres, G., Volinia, S., Alder, H., Nuovo, G.J., Liu, C.G., McGraw, K., Clark, J.A., Sigua, C.A., Chen, D.T., Moscinski, L., Croce, C.M. & List, A.F. (2011) Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. British Journal of Haematology, 153, 24-32.
128. Starczynowski, D.T., Morin, R., McPherson, A., Lam, J., Chari, R., Wegrzyn, J., Kuchenbauer, F., Hirst, M., Tohyama, K., Humphries, R.K., Lam, W.L., Marra, M. & Karsan, A. (2011) Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood, 117, 595-607.
129. Stark, A., Brennecke, J., Russell, R.B. & Cohen, S.M. (2003) Identification of drosophila microRNA targets. PLoS Biology, 1, e60.
130. Suresh, S., McCallum, L., Lu, W., Lazar, N., Perbal, B. & Irvine, A.E. (2011) MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML. Journal of Cell Communication and Signaling, 5, 183-191.
131. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. IARC, Lyon.
132. Taft, R.J., Glazov, E.A., Lassmann, T., Hayashizaki, Y., Carninci, P. & Mattick, J.S. (2009) Small RNAs derived from snoRNAs. RNA, 15, 1233-1240.
133. Torres, A.G., Fabani, M.M., Vigorito, E. & Gait, M.J. (2011) MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection. RNA, 17, 933-943.
134. Vasilatou, D., Papageorgiou, S., Pappa, V., Papageorgiou, E. & Dervenoulas, J. (2010) The role of microRNAs in normal and malignant hematopoiesis. European Journal of Haematology, 84, 1-16.
135. Venturini, L., Battmer, K., Castoldi, M., Schultheis, B., Hochhaus, A., Muckenthaler, M.U., Ganser, A., Eder, M. & Scherr, M. (2007) Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34 + cells. Blood, 109, 4399-4405.
136. Wang, Z.Y. & Chen, Z. (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood, 111, 2505-2515.
137. Wang, V. & Wu, W. (2009) MicroRNA-based therapeutics for cancer. BioDrugs, 23, 15-23.
138. Wang, X.S., Gong, J.N., Yu, J., Wang, F., Zhang, X.H., Yin, X.L., Tan, Z.Q., Luo, Z.M., Yang, G.H., Shen, C. & Zhang, J.W. (2012) MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood, 119, 4992-5004.
139. Wheeler, B.M., Heimberg, A.M., Moy, V.N., Sperling, E.A., Holstein, T.W., Heber, S. & Peterson, K.J. (2009) The deep evolution of metazoan microRNAs. Evolution & Development, 11, 50-68.
140. Whitman, S.P., Maharry, K., Radmacher, M.D., Becker, H., Mrózek, K., Margeson, D., Holland, K.B., Wu, Y.Z., Schwind, S., Metzeler, K.H., Wen, J., Baer, M.R., Powell, B.L., Carter, T.H., Kolitz, J.E., Wetzler, M., Moore, J.O., Stone, R.M., Carroll, A.J., Larson, R.A., Caligiuri, M.A., Marcucci, G. & Bloomfield, C.D. (2010) FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood, 116, 3622-3626.
141. Wong, P., Iwasaki, M., Somervaille, T.C., Ficara, F., Carico, C., Arnold, C., Chen, C.Z. & Cleary, M.L. (2010) The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. Cancer Research, 70, 3833-3842.
142. Wyman, S.K., Knouf, E.C., Parkin, R.K., Fritz, B.R., Lin, D.W., Dennis, L.M., Krouse, M.A., Webster, P.J. & Tewari, M. (2011) Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Research, 21, 1450-1461.
143. Xi, Y., Nakajima, G., Gavin, E., Morris, C.G., Kudo, K., Hayashi, K. & Ju, J. (2007) Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA, 13, 1668-1674.
144. Yekta, S., Shih, I.H. & Bartel, D.P. (2004) MicroRNA-directed cleavage of HOXB8 mRNA. Science, 304, 594-596.
145. Yi, R., Qin, Y., Macara, I.G. & Cullen, B.R. (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes and Development, 17, 3011-3016.
146. Yu, B., Zhao, X., Lee, L.J. & Lee, R.J. (2009) Targeted delivery systems for oligonucleotide therapeutics. The AAPS Journal, 11, 195-203.
147. Zeng, Y., Yi, R. & Cullen, B.R. (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proceedings of the National Academy of Sciences of the United States of America, 100, 9779-9784.
148. Zenz, T., Mohr, J., Eldering, E., Kater, A.P., Bühler, A., Kienle, D., Winkler, D., Dürig, J., van Oers, M.H.J., Mertens, D., Döhner, H. & Stilgenbauer, S. (2009) miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood, 113, 3801-3808.
149. Zhang, H., Luo, X.Q., Feng, D.D., Zhang, X.J., Wu, J., Zheng, Y.S., Chen, X., Xu, L. & Chen, Y.Q. (2011) Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia. Molecular Cancer, 10, 108.
150. Zhu, C., Wang, Y., Kuai, W., Sun, X., Chen, H. & Hong, Z. (2013) Prognostic value of miR-29a expression in pediatric acute myeloid leukemia. Clinical Biochemistry, 46, 49-53.
151. Zimmerman, E.I., Dollins, C.M., Crawford, M., Grant, S., Nana-Sinkam, S.P., Richards, K.L., Hammond, S.M. & Graves, L.M. (2010) Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia. Molecular Pharmacology, 78, 811-817.